UC Davis Cracks the Walnut Genome
News Dec 11, 2015
The information should accelerate the rate of breeding and variety improvement in walnuts and help breeders select for desired traits such as insect and disease resistance, and drought tolerance.
UC Davis geneticists David Neale and Charles Langley worked with the California Walnut Board to develop genetic markers for use with classical walnut breeding. The first step was to sequence the walnut genome, which, unlike most major agricultural crops, had never been sequenced. This represents the first reference genome sequence for a nut crop.
UC Davis has the only walnut breeding program in California. The Walnut Improvement Program, under the direction of plant breeder Chuck Leslie, cooperates with a large number of research partners to develop new walnut varieties.
Walnuts a top export crop for California
The walnut variety Chandler was used for the sequencing project because it is the leading variety of walnut in California. It is grown on about 50 percent of California’s walnut acreage and accounts for more than 70 percent of the trees sold for new plantings. California produces 99 percent of U.S. commercial walnuts, and walnuts are the state’s fourth largest agricultural export.
Consumer demand for nuts is growing, and nutritionists are touting the health attributes of moderate nut consumption in lowering the risk for heart disease. Walnuts are high in omega-3 fatty acids, a healthy form of fatty acids, and can be part of a heart-healthy diet by lowering low-density lipoprotein, or LDL, cholesterol levels in blood.
Growers are also striving to produce nuts more sustainably, particularly in the areas of pest management and drought tolerance.
Genomics adds to traditional breeding
Commercial walnut trees are grafted onto rootstocks, usually a California native black walnut species or a hybrid, known to better withstand diseases, pests and abiotic stress. For the scion, or nut-bearing portion of the tree, an English walnut species is usually used, and breeders are interested in yield, nut quality, harvest date and meeting consumer preferences. Having the genome sequence of the walnut should accelerate its rate of breeding and variety improvement.
Dan Kluepfel, a USDA research plant pathologist in the UC Davis Department of Plant Pathology, is heading a project to breed for walnut rootstock disease resistance. The information will help breeders select for desired traits such as insect and disease resistance and drought tolerance.
In addition to the completed genome sequencing of the Chandler walnut variety, Neale and Langley are sequencing the walnut rootstock species. This composite information will provide additional genomic resources that can be combined with traditional breeding techniques to develop new walnut varieties.
Chandler walnuts, for example, are harvested late in the season, and growers would like earlier harvests. Marker-assisted breeding provides an opportunity to develop early harvesting cultivars with the desirable attributes of Chandler.
“The large repository of walnut genetic material at UC Davis along with new genomic resources lay the groundwork for future breeding of more-sustainable walnut varieties that meet the growing demand for walnuts,” said Neale.
UC Davis and the California Walnut Board, which funded the project, have made the walnut genome sequencing information publicly available at the further information link below.
With approximately 80 percent of our nation's water supply going towards agriculture, it's fair to say it takes a lot of water to grow crops. In a climate with less predictable rainfall patterns and more intense droughts, scientists are working to reduce water consumption by developing more efficient crops.READ MORE
While the sight of black or white truffle being shaved over on pasta is generally considered a sign of dining extravagance, they play an important role in soil ecosystem services. Researchers have now conducted a comparative analysis of eight Pezizomycete fungi, including four species prized as delicacies.READ MORE
As genome editing technologies advance toward clinical therapies, they are raising hopes of a completely new way to treat disease. However, challenges need to be addressed before potential treatments can be widely used in patients. To tackle these challenges, the National Institutes of Health has launched the Somatic Cell Genome Editing program, which has awarded multiple grants including more than $3.6 million to assess the safety of genome editing in human cells and tissues.